Tempus AI prices its IPO at high end of range
Precision medicine company Tempus AI said its initial public offering of 11.1 million shares priced at $37 each, compared with an estimated range of $35 to $37.
Precision medicine company Tempus AI said its initial public offering of 11.1 million shares priced at $37 each, compared with an estimated range of $35 to $37.
